-
1دورية أكاديمية
المؤلفون: Ninoschka C. D’Souza, Julian A. Aiken, Emily G. Hoffman, Sara C. Atherley, Sabrina Champsi, Nadia Aleali, Dorsa Shakeri, Maya El-Zahed, Nicky Akbarian, Mehran Nejad-Mansouri, Parinaz Z. Bavani, Richard L. Liggins, Owen Chan, Michael C. Riddell
المصدر: Frontiers in Pharmacology, Vol 15 (2024)
مصطلحات موضوعية: type 2 diabetes, glucagon, hypoglycemia, counterregulation, somatostatin receptor antagonist, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2024.1302015/fullTest; https://doaj.org/toc/1663-9812Test
-
2صورة
المؤلفون: Ninoschka C. D’Souza, Julian A. Aiken, Emily G. Hoffman, Sara C. Atherley, Sabrina Champsi, Nadia Aleali, Dorsa Shakeri, Maya El-Zahed, Nicky Akbarian, Mehran Nejad-Mansouri, Parinaz Z. Bavani, Richard L. Liggins, Owen Chan, Michael C. Riddell
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, type 2 diabetes, glucagon, hypoglycemia, counterregulation, somatostatin receptor antagonist
الإتاحة: https://doi.org/10.3389/fphar.2024.1302015.s001Test
https://figshare.com/articles/figure/Image1_Evaluating_the_effectiveness_of_a_novel_somatostatin_receptor_2_antagonist_ZT-01_for_hypoglycemia_prevention_in_a_rodent_model_of_type_2_diabetes_TIF/25302367Test